Price
CHART BY
Frequently asked questions
What is Myomo's market capitalization?
The market capitalization of Myomo is $55.45M. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.
What is the Earnings Per Share (EPS) for Myomo?
Myomo's Earnings Per Share (EPS) over the trailing twelve months (TTM) is -$0.343. EPS indicates the company's profitability on a per-share basis.
What are the analyst ratings and target price for Myomo's stock?
Currently, 5 analysts cover Myomo's stock, with a consensus target price of $4.64. Analyst ratings provide insights into the stock's expected performance.
What is Myomo's revenue over the trailing twelve months?
Over the trailing twelve months, Myomo reported a revenue of $43.26M.
What is the EBITDA for Myomo?
Myomo's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is -$9.78M. EBITDA measures the company's overall financial performance.
What is the free cash flow of Myomo?
Myomo has a free cash flow of -$7.29M. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.
How many employees does Myomo have, and what sector and industry does it belong to?
Myomo employs approximately 195 people. It operates in the Health Care sector, specifically within the Medical Distributors industry.
What is the free float of Myomo's shares?
The free float of Myomo is 35.81M. Free float refers to the number of shares available for public trading, excluding restricted shares.
Financials
- Market Cap
- $55.45M
- EPS (TTM)
- -$0.343
- Free Float
- 35.81M
- Revenue (TTM)
- $43.26M
- EBITDA (TTM)
- -$9.78M
- Free Cashflow (TTM)
- -$7.29M
Pricing
- 1D span
- $1.386$1.455
- 52W span
- $0.61$1.88
Analyst Ratings
The price target is $4.64 and the stock is covered by 5 analysts.
Buy
5
Hold
0
Sell
0
Information
Myomo, Inc. is a wearable medical robotics company, which engages in the business of developing, designing, and producing myoelectric orthotics for people with neuromuscular disorders. It is also involved in selling products through various other sales channels including through orthotics and prosthetics providers, veterans’ administration, and to distributors in certain accounts and geographic markets. The company was founded by Stephen Kelly, John McBean, Mira Sahney, and Kailas N. Narendran on September 1, 2004 and is headquartered in Burlington, MA.
- Employees
- 195
- Industries
- Medical Distributors
- Sector
- Health Care
Identifier
- Primary Ticker
- MYO
Knockouts
Real-time data from LSX · Fundamentals & EOD data from FactSet